• Users Online: 615
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe News Contacts Login 
Year : 2019  |  Volume : 3  |  Issue : 4  |  Page : 161-164

Treatment patterns of patients with schizophrenia based on the data from 44,836 outpatients in Russia

1 Depatment of Epidemiology, IQVIA, Frankfurt, Germany
2 Real World Evidence,IQVIA, Moscow, Russia
3 Health & Social, FOM University of Applied Sciences for Economics and Management, Frankfurt, Germany

Correspondence Address:
Dr. Karel Kostev
IQVIA, Unterschweinstiege 2.14, 60549 Frankfurt
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/hm.hm_73_19

Rights and Permissions

Aim: The goal of the present study was to estimate the treatment patterns in outpatients with schizophrenia in Russia. Methods: A total of 44,836 outpatients with schizophrenia treated by 812 psychiatrists in 2018 were selected in the LRx database in Russia. We descriptively analyzed the proportions of patients treated with different therapy classes and drugs. Results: Typical antipsychotics (58.2%) were the therapies with the highest patient proportion, followed by anti-Parkinson drugs (38.3%) and antidepressants (30.6%). The most frequent anti-Parkinson drug was trihexyphenidyl; the most frequent antidepressant was amitriptyline. Conclusions: The findings of this study imply that the proportion of older drugs is higher in schizophrenia therapy in Russia than reported based on samples in Europe and the U.S.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded1741    
    Comments [Add]    
    Cited by others 3    

Recommend this journal